Cancer treatment in the STI571 era: what will change?

Autor:	C L, Sawyers
Rok vydání:	2001
Předmět:	Evidence-Based Medicine Pyrimidines Drug Resistance Neoplasm Leukemia Myelogenous Chronic BCR-ABL Positive Patient Selection Benzamides Imatinib Mesylate Humans Antineoplastic Agents Neoplasm Recurrence Local Stromal Cells Piperazines Gastrointestinal Neoplasms
Zdroj:	Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19
ISSN:	0732-183X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::5b8a32d4a612d441f108dcdbdc16d1c4 https://pubmed.ncbi.nlm.nih.gov/11560965 Zobrazit plný text záznamu